MUFG Americas’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-314,202
Closed -$12.2M 104
2022
Q3
$12.2M Sell
314,202
-6,395
-2% -$257K 0.3% 91
2022
Q2
$11.9M Buy
320,597
+3,423
+1% +$139K 0.27% 98
2022
Q1
$14M Buy
317,174
+9,853
+3% +$427K 0.27% 97
2021
Q4
$13.1M Buy
307,321
+57,931
+23% +$2.43M 0.24% 112
2021
Q3
$10.8M Buy
249,390
+17,206
+7% +$761K 0.19% 117
2021
Q2
$9.93M Buy
232,184
+29,139
+14% +$1.23M 0.16% 124
2021
Q1
$7.85M Buy
203,045
+194,537
+2,287% +$7.36M 0.14% 138
2020
Q4
$306K Buy
8,508
+5,767
+210% +$208K 0.01% 359
2020
Q3
$105K Buy
2,741
+531
+24% +$20.5K ﹤0.01% 429
2020
Q2
$78K Buy
2,210
+1,643
+290% +$59.2K ﹤0.01% 446
2020
Q1
$19K Buy
567
+300
+112% +$11.7K ﹤0.01% 592
2019
Q4
$12K Hold
267
﹤0.01% 677
2019
Q3
$11K Hold
267
﹤0.01% 695
2019
Q2
$11K Hold
267
﹤0.01% 688
2019
Q1
$10K Hold
267
﹤0.01% 785
2018
Q4
$9K Hold
267
﹤0.01% 640
2018
Q3
$10K Hold
267
﹤0.01% 678
2018
Q2
$9K Hold
267
﹤0.01% 790
2018
Q1
$7K Hold
267
﹤0.01% 811
2017
Q4
$7K Hold
267
﹤0.01% 866
2017
Q3
$8K Hold
267
﹤0.01% 888
2017
Q2
$7K Hold
267
﹤0.01% 889
2017
Q1
$7K Sell
267
-190
-42% -$4.62K ﹤0.01% 887
2016
Q4
$10K Hold
457
﹤0.01% 837
2016
Q3
$11K Sell
457
-1,260
-73% -$30.1K ﹤0.01% 831
2016
Q2
$40K Hold
1,717
﹤0.01% 586
2016
Q1
$32K Sell
1,717
-303
-15% -$5.32K ﹤0.01% 624
2015
Q4
$37K Sell
2,020
-192
-9% -$3.44K ﹤0.01% 619
2015
Q3
$36K Buy
2,212
+93
+4% +$1.59K ﹤0.01% 648
2015
Q2
$38K Sell
2,119
-604
-22% -$10.8K ﹤0.01% 656
2015
Q1
$48K Sell
2,723
-31,960
-92% -$505K ﹤0.01% 672
2014
Q4
$459K Sell
34,683
-2,090
-6% -$26.7K 0.02% 390
2014
Q3
$453K Sell
36,773
-39,210
-52% -$494K 0.02% 385
2014
Q2
$970K Sell
75,983
-4,465
-6% -$58.1K 0.03% 298
2014
Q1
$1.09M Buy
80,448
+39,577
+97% +$519K 0.04% 273
2013
Q4
$491K Buy
40,871
+1,120
+3% +$13.2K 0.02% 374
2013
Q3
$466K Sell
39,751
-98,585
-71% -$1.07M 0.02% 385
2013
Q2
$1.28M Buy
+138,336
New +$1.17M 0.03% 474

Other funds holding BSX

MUFG Americas's BSX Position: Q4 2022 in Review

MUFG Americas sold out of Boston Scientific (BSX) in Q4 2022, closing a stake of 314,202 shares — an estimated $12.2M sold.

MUFG Americas first reported a position in BSX in Q2 2013 and held it in 38 quarters. The position peaked at $14M in Q1 2022. 930 funds tracked by Wall St. Rank hold BSX as of Q4 2022.

  • MUFG Americas reported no remaining Boston Scientific position as of Q4 2022 after selling out during the quarter.
  • MUFG Americas sold 314,202 Boston Scientific shares in Q4 2022, an estimated $12.2M.
  • MUFG Americas first reported a position in Boston Scientific in Q2 2013 and held it in 38 quarters.
  • MUFG Americas's Boston Scientific position peaked at $14M in Q1 2022.
  • 930 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2022.

Based on MUFG Americas's 13F filing for Q4 2022.